Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Related TRIB
Earnings Scheduled For March 14, 2017
10 Stocks With Highest Close In Three Weeks
Related VIVO
15 Biggest Mid-Day Losers For Wednesday
Mid-Afternoon Market Update: Seagate Climbs On Strong Q2 Results; Meridian Bioscience Shares Plummet
Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to ... (GuruFocus)

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.

Trinity Biotech plc (NASDAQ: TRIB) is likely to earn $1.16 per share in the next year ending December, 2015. Trinity Biotech's trailing-twelve-month operating margin is 18.98%.

Meridian Bioscience (NASDAQ: VIVO) may earn $1.07 per share in the next year ending September, 2015. Meridian Bioscience's PEG ratio is 2.19.

SurModics (NASDAQ: SRDX) is projected to earn $1.01 per share for the next year ending September, 2015. SurModics' trailing-twelve-month revenue is $56.16 million.

Neogen (NASDAQ: NEOG) is expected to earn $0.94 per share over the next year ending May, 2015. Neogen's trailing-twelve-month ROE is 10.59%.

Posted-In: Diagnostic Substances Industry EPS Estimates small-capTrading Ideas


Related Articles (NEOG + SRDX)

View Comments and Join the Discussion!

Partner Center